MA13ICD-11 MMS 2026-01
Clinical findings of substances chiefly nonmedicinal as to source in blood, blood-forming organs, or the immune system
Index terms
- Clinical findings of substances chiefly nonmedicinal as to source in blood, blood-forming organs, or the immune system
Exclusions from above levels
3B64– Thrombocytopenia- http://id.who.int/icd/entity/1016799900 – abnormalities of coagulation
- http://id.who.int/icd/entity/1191191920 – abnormalities of lipids
Show allHide
Child codes
Sibling codes
MA10– Abnormal serum enzyme levelsMA11– Clinical findings of hormones in blood, blood-forming organs, or the immune systemMA12– Clinical findings of drugs, medicaments or biological substances in blood, blood-forming organs, or the immune systemMA14– Immunological findings in blood, blood-forming organs, or the immune systemMA15– Microbiological findings in blood, blood-forming organs, or the immune systemMA16– Cytological findings in blood, blood-forming organs, or the immune systemMA17– Histological findings in blood, blood-forming organs, or the immune systemMA18– Certain clinical findings of blood chemistryMA19– Certain abnormalities of plasma proteinsMA1A– Elevated erythrocyte sedimentation rate or abnormality of plasma viscosityMA1Y– Other specified clinical findings in blood, blood-forming organs, or the immune system
Foundation entity
Clinical findings of substances chiefly nonmedicinal as to source in blood, blood-forming organs, or the immune system – http://id.who.int/icd/entity/1600579423
Part of: 21: Symptoms, signs or clinical findings, not elsewhere classified